SHLT

SHL Telemedicine (SHLT)

SHL Telemedicine Ltd

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SHLT

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/20	19 : 32	Business Wire	SHL Telemedicine Confirms Discussions Regarding a Possible Investment in its Israeli Activity	NASDAQ:SHLT	SHL Telemedicine Ltd
2024/05/21	14 : 45	Business Wire	SHL Telemedicine Expands Offering in Israel With Groundbreaking At-home Biomarker Blood Test	NASDAQ:SHLT	SHL Telemedicine Ltd
2024/05/16	14 : 45	Business Wire	SHL Telemedicine Announces Official Launch of SmartHeart® D2C Membership in the US Following Successful Soft Launch	NASDAQ:SHLT	SHL Telemedicine Ltd
2024/04/17	19 : 59	IH Market News	US Index Futures See Gains, Oil Prices Dip	NASDAQ:SHLT	SHL Telemedicine Ltd
2024/04/17	18 : 00	Business Wire	SHL Announces Full-Year 2023 Results - Stable Revenue Growth Alongside Groundbreaking Clinical Milestones	NASDAQ:SHLT	SHL Telemedicine Ltd
2024/04/11	15 : 10	Business Wire	Imperial College London Study Shows Groundbreaking Final Results for SHL Telemedicine’s SmartHeart® in Post-ACS Patient Care	NASDAQ:SHLT	SHL Telemedicine Ltd
2024/04/08	15 : 30	Business Wire	SHL Telemedicine’s SmartHeart® Technology Triumphs in US Army Project Convergence – Capstone 4 Experiment	NASDAQ:SHLT	SHL Telemedicine Ltd
2024/04/05	15 : 30	Business Wire	SHL Telemedicine: Invitation to Conference Call Presenting Annual Results 2023	NASDAQ:SHLT	SHL Telemedicine Ltd
2024/03/15	04 : 40	Business Wire	SHL Telemedicine erhält eine Kaufempfehlung mit einem Kursziel von $11,00	NASDAQ:SHLT	SHL Telemedicine Ltd
2024/03/15	04 : 40	Business Wire	SHL Telemedicine reçoit une recommandation d’achat avec un objectif de prix de 11,00 dollars	NASDAQ:SHLT	SHL Telemedicine Ltd
2024/03/14	23 : 40	Business Wire	SHL Telemedicine Receives Buy Rating with $11.00 Price Target	NASDAQ:SHLT	SHL Telemedicine Ltd
2024/02/14	22 : 29	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:SHLT	SHL Telemedicine Ltd
2024/02/01	16 : 30	Business Wire	Imperial College London TELE-ACS Clinical Trial Results, Using SHL Telemedicine’s SmartHeart® Technology, to Be Presented at ACC 24	NASDAQ:SHLT	SHL Telemedicine Ltd
2023/12/28	20 : 15	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SHLT	SHL Telemedicine Ltd
2023/12/27	06 : 10	Edgar (US Regulatory)	Form SC 13D - General statement of acquisition of beneficial ownership	NASDAQ:SHLT	SHL Telemedicine Ltd
2023/12/22	02 : 12	Edgar (US Regulatory)	Form SC 13D - General statement of acquisition of beneficial ownership	NASDAQ:SHLT	SHL Telemedicine Ltd
2023/12/19	16 : 36	Business Wire	SHL Telemedicine and BARMER to Highlight Digital Patient Care at BMC Congress 2024	NASDAQ:SHLT	SHL Telemedicine Ltd
2023/11/27	16 : 00	Business Wire	SHL Telemedicine Introduces SmartHeart® Direct-to-Consumer Membership Plan in the US	NASDAQ:SHLT	SHL Telemedicine Ltd
2023/11/06	15 : 48	Business Wire	SHL Telemedicine Establishes US Nationwide Cardiology Network for ECG Interpretations and Telehealth Visits	NASDAQ:SHLT	SHL Telemedicine Ltd
2023/10/23	14 : 00	Business Wire	SHL Telemedicine Announces Advancements in its Direct-to-Consumer Strategy in the US	NASDAQ:SHLT	SHL Telemedicine Ltd
2023/09/26	15 : 43	Business Wire	SHL Telemedicine's SmartHeart® Technology Shows Remarkable Effects in Mayo Clinic and Imperial College London Trials	NASDAQ:SHLT	SHL Telemedicine Ltd
2023/09/21	20 : 54	Business Wire	SHL Announces Half-Year Results 2023 – Strategic Moves to Accelerate Growth	NASDAQ:SHLT	SHL Telemedicine Ltd
2023/09/11	14 : 34	Business Wire	SHL Telemedicine's SmartHeart® Technology to Take Center Stage at Upcoming VPM 2023 Conference	NASDAQ:SHLT	SHL Telemedicine Ltd
2023/09/06	21 : 00	PR Newswire (US)	SHL Telemedicine: Half-year results 2023 and Conference Call Scheduled for September 21, 2023	NASDAQ:SHLT	SHL Telemedicine Ltd
2023/06/23	05 : 16	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:SHLT	SHL Telemedicine Ltd
2023/06/10	05 : 02	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:SHLT	SHL Telemedicine Ltd
2023/05/16	05 : 01	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:SHLT	SHL Telemedicine Ltd